Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,863 | 121 | 62.5% |
| Unspecified | $1,719 | 16 | 37.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,820 | 22 | $0 (2024) |
| Novo Nordisk Inc | $527.43 | 18 | $0 (2024) |
| BETA BIONICS, INC. | $202.83 | 2 | $0 (2024) |
| Medtronic, Inc. | $185.33 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $163.39 | 3 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $148.75 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.09 | 7 | $0 (2024) |
| Insulet Corporation | $136.20 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $113.34 | 6 | $0 (2024) |
| Abbott Laboratories | $98.91 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,719 | 54 | ABBVIE INC. ($1,756) |
| 2023 | $701.04 | 32 | Medtronic, Inc. ($129.47) |
| 2022 | $267.43 | 9 | Novo Nordisk Inc ($183.49) |
| 2021 | $872.70 | 41 | AstraZeneca Pharmaceuticals LP ($163.39) |
| 2018 | $22.00 | 1 | Senseonics, Incorporated ($22.00) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $22.57 | General |
| 11/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $29.20 | General |
| 09/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.97 | General |
| 08/27/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $115.64 | General |
| Category: Insulin Pump | ||||||
| 08/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.75 | General |
| 08/07/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Automated insulin delivery system | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.33 | General |
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 06/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/22/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Rare Disease | ||||||
| 05/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardio-renal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism | ABBVIE INC. | $1,719 | 16 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,230 | 1,452 | $122,313 | $41,656 |
| 2022 | 13 | 1,675 | 2,235 | $208,424 | $73,589 |
| 2021 | 11 | 947 | 1,031 | $91,630 | $35,564 |
| 2020 | 7 | 187 | 201 | $15,205 | $4,985 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 312 | $62,400 | $21,044 | 33.7% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2023 | 194 | 248 | $11,160 | $4,321 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 40 | $11,000 | $3,985 | 36.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 74 | 76 | $5,700 | $2,151 | 37.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 107 | 126 | $6,930 | $2,010 | 29.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 73 | 87 | $4,350 | $1,876 | 43.1% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 102 | 122 | $6,100 | $1,642 | 26.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 96 | 112 | $6,160 | $1,445 | 23.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 76 | 78 | $2,028 | $1,125 | 55.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 102 | 121 | $5,445 | $1,036 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 130 | $1,040 | $1,019 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 531 | $106,200 | $39,797 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 73 | $20,075 | $7,210 | 35.9% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2022 | 265 | 372 | $16,740 | $6,495 | 38.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 168 | 221 | $12,155 | $3,588 | 29.5% |
| 82306 | Vitamin d-3 level | Office | 2022 | 110 | 115 | $8,625 | $3,307 | 38.3% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2022 | 159 | 214 | $10,700 | $2,931 | 27.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 148 | 197 | $10,835 | $2,544 | 23.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 81 | 111 | $5,550 | $2,380 | 42.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 159 | 214 | $9,630 | $1,864 | 19.4% |
| 82172 | Apolipoprotein level | Office | 2022 | 70 | 72 | $3,600 | $1,502 | 41.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 83 | 86 | $2,236 | $1,253 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 13 | $1,950 | $669.44 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 16 | $128.00 | $48.00 | 37.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 187 | $37,400 | $16,167 | 43.2% |
About Maria Weir
Maria Weir is a Adult Health healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1033485917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Weir has received a total of $4,582 in payments from pharmaceutical and medical device companies, with $2,719 received in 2024. These payments were reported across 137 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,863).
As a Medicare-enrolled provider, Weir has provided services to 4,039 Medicare beneficiaries, totaling 4,919 services with total Medicare billing of $155,793. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Chesterfield, MO
- Active Since 03/26/2012
- Last Updated 03/26/2012
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1033485917
Products in Payments
- ARMOUR THYROID (Drug) $1,528
- Ozempic (Drug) $280.58
- iLet Bionic Pancreas (Device) $202.83
- Rybelsus (Drug) $188.87
- FARXIGA (Drug) $163.39
- Kerendia (Drug) $148.75
- Omnipod (Device) $136.20
- MINIMED 780G (Device) $129.47
- TRADJENTA (Drug) $82.08
- LEQVIO (Drug) $80.53
- Vascepa (Drug) $77.46
- AFREZZA (Drug) $65.86
- GVOKE HYPOPEN (Drug) $63.42
- JANUVIA (Drug) $62.13
- SYNTHROID (Drug) $56.19
- Repatha (Biological) $56.18
- JARDIANCE (Drug) $51.03
- Korlym (Drug) $47.39
- STRENSIQ (Biological) $41.45
- TOUJEO (Biological) $40.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Chesterfield
Racquel Frisella, Agpcnp-Bc, AGPCNP-BC
Adult Health — Payments: $91,068
Laurencia Klipfel, Rn, Aprn-Bc, RN, APRN-BC
Adult Health — Payments: $55,417
Mr. Patrick Behnke, Np, NP
Adult Health — Payments: $24,073
Kelly Beck
Adult Health — Payments: $5,571
Jamie Joy, Agpcnp-Bc, AGPCNP-BC
Adult Health — Payments: $5,008
Julie Lambert, Anp-Bc, ANP-BC
Adult Health — Payments: $4,448